long covid

AMA Update 391: The latest long COVID research on symptoms, testing and treatments with Akiko Iwasaki, PhD

30 de noviembre de 2023 casimedicos AMA Update 00:13:52 0 Comments

Leading long COVID researcher, Akiko Iwasaki, PhD, sterling professor of immunobiology at Yale University, joins to provide an update on the latest long COVID studies and clinical trials—and what their findings mean for physicians and patients. Dr. Iwasaki discusses what we know now about the causes of long COVID, the ongoing challenges with diagnosing it and the timeline for potential treatments. American Medical Association CXO Todd Unger hosts.

🎞️ Watch Dr. Iwasaki’s previous episode here: https://youtu.be/kONtiiHsbPw?si=TMIr95DMfvuYDF3f

🔬 Distinguishing features of long COVID identified through immune profiling published in Nature: https://www.nature.com/articles/s41586-023-06651-y

📰 Scientists Offer a New Explanation for Long Covid New York Times article: https://www.nytimes.com/2023/10/16/health/long-covid-serotonin.html

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 380: COVID-19 vaccine costs, Paxlovid price change, new studies on long COVID symptoms and more

1 de noviembre de 2023 casimedicos AMA Update 00:12:40 0 Comments

How much does COVID-19 cost? AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, breaks down how much COVID could cost you. From the risk of not getting vaccinated and the new HV.1 variant, to vaccines covered by insurance and coronavirus treatment costs in the U.S. American Medical Association CXO Todd Unger hosts.

💉 Searching «COVID shots near me»? Use the COVID vaccine finder: https://www.vaccines.gov/search/

🔬 The Journal of Infectious Diseases article «COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID Complications» via Oxford Academic: https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiad395/7328977

📖 BMC Infectious Diseases article «Prevalence and predictors of post-COVID-19 symptoms in general practice – a registry-based nationwide study» via University of Bergen Norway: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-023-08727-6

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 353: Eris and Pirola COVID variants, plus CDC flesh-eating bacteria warning with Andrea Garcia, JD, MPH

6 de septiembre de 2023 casimedicos AMA Update 00:11:47 0 Comments

COVID cases continue to rise in the U.S. due to the new EG.5, or Eris, variant. AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, analyzes the increase in COVID hospitalizations and shares the latest news about the EG.5 and BA.2.86, or Pirola, variants. Plus, the CDC Health Advisory on fatal Vibrio vulnificus (or V. vulnificus) infections and what physicians and patients need to know about it. American Medical Association CXO Todd Unger hosts.

🦠 Centers for Disease Control and Prevention «Severe Vibrio vulnificus Infections in the United States Associated with Warming Coastal Waters»: https://emergency.cdc.gov/han/2023/han00497.asp

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 338: New long COVID clinical trials, FDA approves postpartum depression pill & RSV shot for babies

9 de agosto de 2023 casimedicos AMA Update 00:10:12 0 Comments

HHS forms the Office of Long COVID Research and Practice, and the NIH launches new Long COVID clinical trials. AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, discusses these new Long COVID developments, along with a study with insights into the maternal health crisis in the US and the FDA’s approval of a pill to treat postpartum depression. Plus, NIAID’s new director, the new head of the CDC and ACIP’s RSV shot recommendation for babies. American Medical Association CXO Todd Unger hosts.

🥼 Learn more about the AMA Recovery Plan for America’s Physicians: https://bit.ly/AMA_RecoveryPlan

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 305: 12 symptoms of long COVID, FDA Paxlovid approval & mpox vaccines with Andrea Garcia, JD, MPH

31 de mayo de 2023 casimedicos AMA Update 00:11:49 0 Comments

A new study outlines the 12 symptoms of long COVID, and the FDA fully approves Paxlovid for adults. AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, also discusses who should get a monkeypox vaccine ahead of festival season this summer. American Medical Association CXO Todd Unger hosts.
Akiko Iwasaki, PhD, shares what you need to know about long COVID 🦠 Watch here: https://youtu.be/kONtiiHsbPw

Read More

AMA Update 301: Long COVID: New research, common symptoms, long-term effects and treatments with Akiko Iwasaki, PhD

22 de mayo de 2023 casimedicos AMA Update 00:16:03 0 Comments

Akiko Iwasaki, PhD, returns to AMA Update to share the latest science behind long COVID, including how many people are still suffering, most common symptoms and what we know about treatments like Paxlovid. She also shares guidance for physicians on diagnosing long COVID, treating post-COVID patients and new research to watch. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 205: Bivalent boosters for kids, long COVID study, monkeypox decline & more with Andrea Garcia, JD, MPH

17 de octubre de 2022 casimedicos AMA Update 00:11:25 0 Comments

AMA’s Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, shares details of the FDA’s authorization for COVID boosters for kids 5 to 11, early Pfizer data on the bivalent booster and a study on long COVID, plus the latest on monkeypox and Ebola. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 139: Akiko Iwasaki, PhD, on the latest long COVID research

11 de abril de 2022 casimedicos AMA Update 00:15:19 0 Comments

AMA CXO Todd Unger discusses the latest research on long COVID with Akiko Iwasaki, PhD, the Sterling Professor of Immunobiology at Yale University and a principal investigator at the Howard Hughes Medical Institute.

Read More